Telomir Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	52	123	-	-	-
Enterprise Value	51	122	-	-	-
Last Close Price	1.67	4.12	-	-	-
PB Ratio	-	190.63	-	-	-
P/TBV Ratio	-	190.63	-	-	-
Debt / Equity Ratio	-0.58	0.14	0.18	-0.62	-0.86
Quick Ratio	0.62	1.86	0.00	0.00	-
Current Ratio	0.75	1.94	0.33	0.05	-
Return on Equity (ROE)	-872.57%	-810.18%	-1045.36%	-	-
Return on Assets (ROA)	-391.62%	-250.96%	-102.18%	-	-
Return on Capital (ROIC)	-529.03%	-318.60%	-132.78%	-	-
Earnings Yield	-24.17%	-13.49%	-	-	-
Buyback Yield / Dilution	-9.13%	-8.18%	-1.77%	-	-

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q